From a Pitchbook study of 67 funds dedicated to the sector, the median IRR has been 10.02% from 2007 to the present. The best funds in the top quartile (25% best) have obtained a 12.15% return.<\/p>\n
The most outstanding funds (Top3)<\/b><\/p>\n
<\/b>1.\u00a0CID Capital Opportunity Fund I<\/span>:<\/p>\n With more than 32 years of experience, CICcap has a private equity and venture capital division. In the PE division, they invest in companies with a turnover between 10 and 75 MM$, with a minimum EBITDA of 2MM$ in a transaction size between 10 and 70 MM$. They usually require majority control. Investees in the sector include http:\/\/www.celleration.com\/<\/span> and https:\/\/www.brainscope.com\/<\/a><\/p>\n 2.\u00a0Excellence Partners<\/span><\/p>\n 3.\u00a0Green Equity Investors V<\/a><\/p>\n The most relevant recent operations have been David's Bridal<\/a>Priscilla of Boston, November 2006, Priscilla of Boston, April 2007, The Container Store<\/a>, July 2007 and Whole Foods Market<\/a>, November 2008.<\/p>\n Most recent operation:<\/b> Frazier Healthcare has agreed to acquire AndersonBrecon<\/b><\/p>\n Frazier Healthcare<\/a> has agreed to acquire AndersonBrecon<\/span>, <\/b>the pharmaceutical packaging business of AmerisourceBergen (NYSE: ABC), for US $$ 308 million in cash. Greenspring Associates<\/a>, QIC Private Equity Global<\/a> and Thomas, McNerney & Partners are joining Frazier in the acquisition. Based in Illinois, AndersonBrecon provides packaging services for various end markets in the healthcare space, including consumer healthcare, biologics, generics, OTC, animal health and medical device suppliers. Frazier, which is using its Healthcare Fund VI for the acquisition, will merge AndersonBrecon with Packaging Coordinators<\/a> portfolio company, a provider of pharmaceutical and biotechnology packaging, to offer specialised packaging services on a global scale.<\/b><\/p>\n Diego Guti\u00e9rrez Zarza<\/p>\n ABRA INVEST
\nWeb:\u00a0www.abra-invest.com<\/a><\/p>\n